HighIn VitroActivity of the Novel Spiropyrimidinetrione AZD0914, a DNA Gyrase Inhibitor, against Multidrug-Resistant Neisseria gonorrhoeae Isolates Suggests a New Effective Option for Oral Treatment of Gonorrhea

Two cases of verified clinical failures using internationally recommended first-line cefixime for gonorrhoea treatment, Norway, 2010

(2017) M Unemo et al.   Eurosurveillance

Prospects for Developing New Antibacterials Targeting Bacterial Type IIA Topoisomerases

(2014) Tihomir Tomašić et al.   CURRENT TOPICS IN MEDICINAL CHEMISTRY

Non-quinolone Inhibitors of Bacterial Type IIA Topoisomerases: A Feat of Bioisosterism

(2013) Claudine Mayer et al.   CHEMICAL REVIEWS

2012 European guideline on the diagnosis and treatment of gonorrhoea in adults

(2013) C Bignell et al.   INTERNATIONAL JOURNAL OF STD & AIDS

Neisseria gonorrhoeae Treatment Failure and Susceptibility to Cefixime in Toronto, Canada

(2013) Vanessa G. Allen et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Phenotypic and genetic characterization of the first two cases of extended-spectrum-cephalosporin-resistant Neisseria gonorrhoeae infection in South Africa and association with cefixime treatment failure

(2013) D. A. Lewis et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Failure of 500 mg of ceftriaxone to eradicate pharyngeal gonorrhoea, Australia

(2013) M. Y. Chen et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

One confirmed and one suspected case of pharyngeal gonorrhoea treatment failure following 500mg ceftriaxone in Sydney, Australia

(2013) Phillip J. Read et al.   Sexual Health

Emergence of multidrug-resistant, extensively drug-resistant and untreatable gonorrhea

(2012) Magnus Unemo et al.   Future Microbiology

Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia, Spain

(2012) J. Camara et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Antibiotic resistance in Neisseria gonorrhoeae: origin, evolution, and lessons learned for the future

(2011) Magnus Unemo et al.   Annals of the New York Academy of Sciences

Is Neisseria gonorrhoeae Initiating a Future Era of Untreatable Gonorrhea?: Detailed Characterization of the First Strain with High-Level Resistance to Ceftriaxone

(2011) Makoto Ohnishi et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

High-Level Cefixime- and Ceftriaxone-Resistant Neisseria gonorrhoeae in France: NovelpenAMosaic Allele in a Successful International Clone Causes Treatment Failure

(2011) Magnus Unemo et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Exploiting bacterial DNA gyrase as a drug target: current state and perspectives

(2011) Frédéric Collin et al.   APPLIED MICROBIOLOGY AND BIOTECHNOLOGY

The Gonococcus fights back: is this time a knock out?

(2010) D. A. Lewis   SEXUALLY TRANSMITTED INFECTIONS

Meeting the public health challenge of multidrug- and extensively drug-resistantNeisseria gonorrhoeae

(2009) John W Tapsall et al.   Expert Review of Anti-Infective Therapy

Phenotypic and genetic characterization of the 2008 WHO Neisseria gonorrhoeae reference strain panel intended for global quality assurance and quality control of gonococcal antimicrobial resistance surveillance for public health purposes

(2009) M. Unemo et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Two cases of failed ceftriaxone treatment in pharyngeal gonorrhoea verified by molecular microbiological methods

(2009) J. Tapsall et al.   JOURNAL OF MEDICAL MICROBIOLOGY